the next generation of novel agents in development for aggressive b-cell lymphoma
Published 1 year ago • 94 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:50
the value of moving novel agents into the frontline setting in all
-
1:15
bringing novel agents to the frontline setting in myeloma
-
6:47
sequencing the single cell – adventures in genomics
-
4:46
glofitamab induces durable complete remissions in patients with relapsed large b-cell lymphoma
-
21:24
cell surface markers: cd3, cd4, cd8, cd19, cd28, cd16, cd56
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:53
autohct in dlbcl in the car-t era
-
3:55
novel agent cd20-tcb induces cr in r/r b-cell nhl
-
1:01
next-generation sequencing: a breakthrough in sequencing technology
-
2:09
integrating novel agents into the treatment of multiple myeloma
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
1:12
promising novel agents for hemophilia a/b: gene therapies and extended half-life products
-
1:42
applying next-generation sequencing in the diagnosis of rare inherited anemias
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more
-
1:17
novel agents to improve outcomes for patients with multiple myeloma in the salvage setting
-
2:12
using a novel machine learning model to analyze and predict the outcomes of patients with ndmm